The board meeting for Recursion Pharmaceuticals Inc - Ordinary Shares - Class A is scheduled for today, for the purpose of Recursion Pharmaceuticals Inc Second Quarter Earnings Results for 2025See details
Recursion Pharmaceuticals Inc - Ordinary Shares - Class A - RXRX - stock price prediction, stock price target, analyst ratings from 8 analysts
Recursion Pharmaceuticals Inc - Ordinary Shares - Class A has a share price target of US$ 6, revenue growth forecast of 27.2%, and profit growth estimate of -29.3% for FY25, based on top 8 analyst calls.